Azithromycin

It's an RNA test approved by the New York State Department of Health.

I give her at the time Mepron, Azithromax, Atovaquone, and Azithromycin, which worked basically 30 years ago.

And within weeks following, she had enough strength to get out of the wheelchair, start walking.

The woman is now skiing down mountains and is basically much better.

I wouldn't treat it with kid gloves.

Yeah, I'd actually treat it with Zithromycin and cough suppressants like Tesla on pearls and a whole shit ton of hot toddies because they're in honey and some whiskey.

So I'll make gummy bear.

should just bring the trash can back i

Cool.

Let me go to the shelf.

Look, Zithromycin handled next.

So France.

But the body of the progress note is gonna focus on, okay, what actually happened since that note? I've already given context in that first line.

And then my next line is gonna be, was started on Rocephin and Azithromycin and continues on this.

So I'm addressing what are we doing about that issue we identified in line one.

And then the next line is gonna be subjectively how the patient feels.

It's positive.

I give her Mepron and Zithromax, which I published at the conference the year before.

And lo and behold, she starts walking out of a wheelchair after five years.

And she was on five years of antibiotics for chronic Lyme.

We added rifampin to doxy and dapsone.

It lowered the biofilm persisters even more.

We added Zithromax.

So I came up with it because we found this four drug regimen.

They start to feel better and they save it for a rainy day, right? They save it in case they need something else.

And so even though biaxin was more efficacious in a test against Zithromax, The doctor said, well, really, no one's taking Biaxon for the full prescription.

And so really, is it that much more effective than Zithromax? And so they came to market and the doctor said, well, I don't really care that much about the efficacy.

It's probably a point of parody, but it has less pills you take.

And

The doctors liked it because it was easier to write a prescription.

And the moms and dads liked it because it was easier for the kids to take.

And so they reversed their position in the market, which was 1 to 4, meaning Baxam was winning 4 to 1 over Zithromax.

So one of the treatments that I've received over the years was an antibiotic that's in the Z-Pak.

It's the azithromycin.

And azithromycin does cover partially Babesia.

But what I've learned, having been involved in ILADS and learning from brilliant people like Dr. Henry Linder and others, you know, founding members of ILADS and from the literature, it's that once Babesia becomes chronic, it can be very challenging to get rid of it.

And when you take the treatment away, especially if you become ill with something like COVID, which for many people could be immunosuppressive and let other infections rise up again, you know, you catch COVID, it harms your immune system effectively.

And that is the other hat that I wear.

So my group, we have a study actually of 3,200 patients that can be enrolled and some of those patients will receive antibiotics for your asthma.

Now, interestingly, it's the same antibiotic that I was talking about before, the Z-Pak antibiotic, azithromycin.

It does not work on stationary phase.

Azithromycin does not work on stationary phase.

Everyone knows this that prescribes.

Okay.

Macrolides are a classic class that work by binding to the 50S subunit of the bacterial ribosome, effectively shutting down the bacteria's ability to synthesize proteins.

Azithromycin was our first generation.

Right.

It worked well, but had stability issues in stomach acid, so we tweaked the structure to create the second generation, clarithromycin, which was far more stable.